Author Middel, Peter

• 2019 | Journal Article | 
  ​ ​Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer​
  Conradi, L.-C.; Spitzner, M.; Metzger, A.-L.; Kisly, M.; Middel, P.; Bohnenberger, H. & Gaedcke, J. et al.​ (2019) 
  BMC Cancer, 19(1) pp. 880​.​ DOI: https://doi.org/10.1186/s12885-019-6051-0 
  ​Details  DOI  PMID  PMC 

• 2018 | Journal Article
  ​ ​Cold Storage Injury to Rat Small-bowel Transplants—Beneficial Effect of a Modified HTK Solution​
  Lautenschläger, I.; Pless-Petig, G.; Middel, P.; de Groot, H.; Rauen, U. & Stojanovic, T.​ (2018) 
  Transplantation, 102(10) pp. 1666​-1673​.​ DOI: https://doi.org/10.1097/TP.0000000000002318 
  ​Details  DOI 

• 2018 | Journal Article | 
  ​ ​Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer​
  Scheel, A. H.; Penault-Llorca, F.; Hanna, W.; Baretton, G.; Middel, P.; Burchhardt, J. & Hofmann, M. et al.​ (2018) 
  Diagnostic Pathology, 13(1).​ DOI: https://doi.org/10.1186/s13000-018-0696-x 
  ​Details  DOI 

• 2017 | Journal Article | 
  ​ ​The Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer​
  Rühlmann, F. ; Nietert, M. M. ; Sprenger, T. ; Wolff, H. A. ; Homayounfar, K. ; Middel, P. & Bohnenberger, H.  et al.​ (2017) 
  Journal of Cancer, 8(7) pp. 1229​-1237​.​ DOI: https://doi.org/10.7150/jca.16980 
  ​Details  DOI  PMID  PMC  WoS 

• 2016 | Journal Article | 
  ​ ​beta-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases​
  Bleckmann, A. ; Conradi, L.-C. ; Menck, K. ; Schmick, N. A.; Schubert, A.; Rietkoetter, E. & Arackal, J. et al.​ (2016) 
  Clinical & Experimental Metastasis, 33(4) pp. 309​-323​.​ DOI: https://doi.org/10.1007/s10585-016-9780-3 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article
  ​ ​HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer​
  Styczen, H.; Nagelmeier, I.; Beißbarth, T. ; Nietert, M. M. ; Homayounfar, K. ; Sprenger, T.   & Boczek, U. et al.​ (2015) 
  Oncotarget, 6(17) pp. 15065​-15076​.​
  ​Details  PMID  PMC  WoS 

• 2015 | Journal Article
  ​ ​Comprehensive lymph node morphometry in rectal cancer using acetone compression​
  Scheel, A. H.; Reineke, R. A.; Sprenger, T.; Lokka, S.; Kitz, J.; Ghadimi, B. M. & Rueschoff, J. et al.​ (2015) 
  Journal of Clinical Pathology, 68(6) pp. 458​-464​.​ DOI: https://doi.org/10.1136/jclinpath-2014-202555 
  ​Details  DOI  PMID  PMC  WoS 

• 2014 | Journal Article
  ​ ​HER2 and HER3 expression in hepatic metastases of colorectal cancer: New targets for specific treatment approaches?​
  Conradi, L.-C.; Styczen, H.; Sprenger, T.; Wolff, H. A.; Middel, P.; Nagelmeier, I. & Rüschoff, J. et al.​ (2014) 
  Journal of Clinical Oncology, 32(3_suppl) pp. 567​-567​.​
  ​Details  WoS 

• 2013 | Journal Article | 
  ​ ​Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse Event.​
  Quack, H.; Erpenbeck, L.; Wolff, H. A.; Sprenger, T.; Seitz, C. S.; Schön, M. P. & Neumann, S. et al.​ (2013) 
  Case reports in oncology, 6(3) pp. 609​-615​.​ DOI: https://doi.org/10.1159/000357166 
  ​Details  DOI  PMID  PMC 

• 2013 | Conference Abstract
  ​ ​HER-2 and HER-3 expression in locally advanced rectal cancer and metachronous metastases: new targets for treatment approaches?​
  Conradi, L.-C. ; Styczen, H.; Sprenger, T. ; Wolff, H. A. ; Middel, P.; Nagelmeier, I. & Rüschoff, J. R.  et al.​ (2013)
  Onkologie, 36 
  Basel​: Karger.
  ​Details  WoS 

• 2013 | Journal Article
  ​ ​Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival​
  Sprenger, T. ; Conradi, L.-C. ; Beißbarth, T. ; Ermert, H.; Homayounfar, K. ; Middel, P. & Rüschoff, J. R.  et al.​ (2013) 
  Cancer, 119(1) pp. 26​-35​.​ DOI: https://doi.org/10.1002/cncr.27703 
  ​Details  DOI  PMID  PMC  WoS 

• 2013 | Journal Article | 
  ​ ​Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: Re-analysis of the SATURN study​
  Mazieres, J.; Brugger, W.; Cappuzzo, F.; Middel, P.; Frosch, A.; Bara, I. & Klingelschmitt, G. et al.​ (2013) 
  Lung Cancer, 82(2) pp. 231​-237​.​ DOI: https://doi.org/10.1016/j.lungcan.2013.07.016 
  ​Details  DOI  PMID  PMC  WoS 

• 2013 | Journal Article
  ​ ​Frequency of HER-2 Positivity in Rectal Cancer and Prognosis​
  Conradi, L.-C. ; Styczen, H.; Sprenger, T. ; Wolff, H. A. ; Roedel, C.; Nietert, M. M.   & Homayounfar, K.  et al.​ (2013) 
  American Journal of Surgical Pathology, 37(4) pp. 522​-531​.​ DOI: https://doi.org/10.1097/PAS.0b013e318272ff4d 
  ​Details  DOI  PMID  PMC  WoS 

• 2013 | Journal Article
  ​ ​Preoperative Chemoradiation Therapy With Capecitabine/Oxaliplatin and Cetuximab in Rectal Cancer: Long-Term Results of a Prospective Phase 1/2 Study​
  Fokas, E.; Conradi, L.-C. ; Weiss, C.; Sprenger, T. ; Middel, P.; Rau, T. & Dellas, K. et al.​ (2013) 
  International Journal of Radiation Oncology*Biology*Physics, 87(5) pp. 992​-999​.​ DOI: https://doi.org/10.1016/j.ijrobp.2013.09.011 
  ​Details  DOI  PMID  PMC  WoS 

• 2012 | Journal Article
  ​ ​HER2/neu expression in locally advanced rectal cancer cUICC II/III and its correlation with long-term prognosis​
  Conradi, L.-C.; Styczen, H.; Sprenger, T.; Becker, H.; Ghadimi, M. B.; Beißbarth, T.   & Middel, P. et al.​ (2012) 
  Journal of Clinical Oncology, 30(4, Suppl.) pp. 493​-493​.​ DOI: https://doi.org/10.1200/jco.2012.30.4_suppl.493 
  ​Details  DOI 

• 2012 | Conference Abstract
  ​ ​Pyloric gland adenoma of the cystic duct with malignant transformation​
  Schaefer, I.-M.; Cameron, S.; Middel, P.; Homayounfar, K.; Ramadori, G.; Schworer, H. & Veits, L. et al.​ (2012)
  Histopathology, 61 pp. 145​-146. ​29th Congress of the International-Academy-of-Pathology​, Cape Town, SOUTH AFRICA.
  Hoboken​: Wiley-blackwell.
  ​Details  WoS 

• 2012 | Conference Abstract
  ​ ​Cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative triple treatment for rectal cancer (CET-CAPOX-RT-Phase-I/II Study): Influence on long-term survival and relevance of biomarkers​
  Liersch, T. ; Conradi, L.-C. ; Sprenger, T. ; Middel, P.; Suelberg, H.; Roedel, F. & Rüschoff, J. R.  et al.​ (2012)
  Journal of Clinical Oncology, 30(15) ​48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)​, Chicago, IL.
  Alexandria​: Amer Soc Clinical Oncology.
  ​Details  WoS 

• 2012 | Conference Abstract
  ​ ​HER-2 in locally advanced rectal cancer (cUICC II/III): positivity rate and prognostic value​
  Conradi, L.-C. ; Styczen, H.; Sprenger, T. ; Wolff, H. A. ; Homayounfar, K. ; Becker, H. & Ghadimi, M. B.  et al.​ (2012)
  British Journal of Surgery, 99 ​99th Annual Congress of the Swiss-Society-of-Surgery​, Davos, SWITZERLAND.
  Malden​: Wiley-blackwell.
  ​Details  WoS 

• 2012 | Conference Abstract
  ​ ​HER2 status in locally advanced rectal cancer and metachronous metastases: Opportunity for a new therapeutic approach?​
  Conradi, L.-C. ; Styczen, H.; Sprenger, T. ; Homayounfar, K. ; Wolff, H. A. ; Bleckmann, A.   & Rüschoff, J. R.  et al.​ (2012)
  Journal of Clinical Oncology, 30(15) , Chicago, IL.
  Alexandria​: Amer Soc Clinical Oncology.
  ​Details  WoS 

• 2012 | Conference Abstract
  ​ ​ANALYSIS OF PFS AND OS FROM THE SATURN STUDY ACCORDING TO EGFR IHC STATUS USING THE H-SCORE READING METHOD​
  Mazieres, J.; Brugger, W.; Cappuzzo, F.; Middel, P.; Frosch, A.; Bara, I. & Klingelschmitt, G. et al.​ (2012)
  Annals of Oncology, 23 ​37th Congress of the European-Society-for-Medical-Oncology (ESMO)​, Vienna, AUSTRIA.
  Oxford​: Oxford Univ Press.
  ​Details  WoS 

Researcher

Sort

Items per Page